|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0019004,
umls-concept:C0022660,
umls-concept:C0034656,
umls-concept:C0079189,
umls-concept:C0205390,
umls-concept:C0231242,
umls-concept:C0243026,
umls-concept:C0441889,
umls-concept:C0596901,
umls-concept:C1442160
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-7-30
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Sepsis is the leading cause of acute renal failure. Intermittent hemodialysis (IHD) is a common treatment for patients with acute renal failure. However, standard hemodialysis membranes achieve only little diffusive removal of circulating cytokines. Modified membranes may enable both successful IHD treatment and simultaneous diffusive cytokine removal.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1523-6838
|
|
pubmed:author |
pubmed-author:BaldwinIanI,
pubmed-author:BellomoRinaldoR,
pubmed-author:BoyceNeilN,
pubmed-author:DavenportPiersP,
pubmed-author:FealyNigelN,
pubmed-author:GoehlHermannH,
pubmed-author:Haase-FielitzAnjaA,
pubmed-author:HaaseMichaelM,
pubmed-author:MorgeraStanislaoS,
pubmed-author:NeumayerHans-HellmutHH,
pubmed-author:StorrMarkusM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
296-304
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17660031-Acute Kidney Injury,
pubmed-meshheading:17660031-Adult,
pubmed-meshheading:17660031-Aged,
pubmed-meshheading:17660031-Cross-Over Studies,
pubmed-meshheading:17660031-Cytokines,
pubmed-meshheading:17660031-Double-Blind Method,
pubmed-meshheading:17660031-Female,
pubmed-meshheading:17660031-Humans,
pubmed-meshheading:17660031-Male,
pubmed-meshheading:17660031-Membranes, Artificial,
pubmed-meshheading:17660031-Middle Aged,
pubmed-meshheading:17660031-Renal Dialysis,
pubmed-meshheading:17660031-Sepsis
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial.
|
|
pubmed:affiliation |
Intensive Care Unit, Austin Hospital, University of Melbourne, Australia.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
